Cancer stem cells (CSCs) play a central role in tumor progression, recurrence, and resistance to conventional therapies, making them a critical focus in oncology research. This review provides a comprehensive analysis of CSC biology, emphasizing their self-renewal, differentiation, and dynamic interactions with the tumor microenvironment (TME). Key signaling pathways, including Wnt, Notch, and Hedgehog, are discussed in detail to highlight their potential as therapeutic targets. Current methodologies for isolating CSCs are critically examined, addressing their advantages and limitations in advancing precision medicine. Emerging technologies, such as CRISPR/Cas9 and single-cell sequencing, are explored for their transformative potential in unraveling CSC heterogeneity and informing therapeutic strategies. The review also underscores the pivotal role of the TME in supporting CSC survival, promoting metastasis, and contributing to therapeutic resistance. Challenges arising from CSC-driven tumor heterogeneity and dormancy are analyzed, along with strategies to mitigate these barriers, including novel therapeutics and targeted approaches. Ethical considerations and the integration of artificial intelligence in designing CSC-specific therapies are discussed as essential elements of future research. The manuscript advocates for a multi-disciplinary approach that combines innovative technologies, advanced therapeutics, and collaborative research to address the complexities of CSCs. By bridging existing gaps in knowledge and fostering advancements in personalized medicine, this review aims to guide the development of more effective cancer treatment strategies, ultimately improving patient outcomes.
癌症干细胞在肿瘤进展、复发及对常规治疗抵抗中发挥核心作用，已成为肿瘤学研究的关键焦点。本综述系统分析了癌症干细胞的生物学特性，重点阐述其自我更新、分化能力以及与肿瘤微环境的动态相互作用。通过详细探讨Wnt、Notch和Hedgehog等关键信号通路，揭示了其作为治疗靶点的潜在价值。文章批判性评估了当前分离癌症干细胞的技术方法，剖析了这些方法在推进精准医疗中的优势与局限。同时探讨了CRISPR/Cas9基因编辑和单细胞测序等新兴技术在解析癌症干细胞异质性、指导治疗策略方面的变革性潜力。本综述特别强调了肿瘤微环境在维持癌症干细胞存活、促进转移及导致治疗抵抗中的关键作用，系统分析了癌症干细胞驱动的肿瘤异质性与休眠状态带来的挑战，并提出了包括新型治疗药物和靶向策略在内的应对方案。文中还讨论了人工智能在癌症干细胞特异性疗法设计中的整合应用及相关的伦理考量，指出这些要素对未来研究至关重要。本文主张采用多学科交叉的研究策略，通过创新技术、先进疗法与协同研究的有机结合来应对癌症干细胞的复杂性。通过弥合现有知识空白并推动个体化医疗发展，本综述旨在为制定更有效的癌症治疗策略提供指导，最终改善患者临床预后。
肿瘤(癌症)患者之家